## FCX: Freeport-McMoRan, Inc. - XLB: Basic Materials

### Executive Summary

STRENGTH thesis confirmed: MRS_10 at 4.1% in lower entry zone (3.0-6.0%), top quartile (87th pct) cross-sectional ranking. Short-term MRS_5 (2.0%) confirms momentum alignment. Strong momentum (+1.2% 5-day acceleration). Outperforming sector by 5.4%.

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($42.20)
- **If Wrong:** Exit if MRS_10 drops below entry zone or breaks stop
- **Invalidation:** MRS_10 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 1, Bearish: 0)

**1. Levi & Korsinsky Helps Shareholders SueWallSt After Freeport-McMoRan Inc. Stock Drops**
- Source: WIVB News 4 | 20251205T200758 | Neutral | Relevance: 99%
-  Levi & Korsinsky has filed a class action lawsuit on behalf of investors who lost money due to alleged securities fraud by Freeport-McMoRan Inc. The period of alleged fraud is between February 15, 2022, and September 24, 2025. Shareholders affected are encouraged to contact Levi & Korsinsky for more information.

**2. Pomerantz LLP Highlights Class Action Filing Against Freeport-McMoran Inc. â€“ FCX**
- Source: WRIC ABC 8News | 20251205T083700 | Neutral | Relevance: 99%
-  Pomerantz LLP has announced a class action lawsuit against Freeport-McMoran Inc. (NYSE: FCX) for alleged securities fraud. The lawsuit stems from two incidents in September 2025 where mining operations were suspended at the Grasberg Block Cave in Indonesia, leading to worker injuries and fatalities, and significant drops in the company's stock price. Investors who purchased Freeport securities during the Class Period have until January 12, 2026, to seek appointment as Lead Plaintiff.

**3. Levi & Korsinsky Moves to SueWallSt for Freeport-McMoRan Inc. Investors That Lost Money**
- Source: WRIC ABC 8News | 20251204T193700 | Neutral | Relevance: 99%
-  Levi & Korsinsky has filed a class action lawsuit against Freeport-McMoRan Inc. on behalf of investors who reportedly lost money due to alleged securities fraud between February 15, 2022, and September 24, 2025. The firm, known for its expertise in securities litigation, encourages affected investors to contact them for more information or to take action. They also promote their "SueWallSt" podcast and WhatsApp channel for updates on class action news.

**4. FCX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Investors of Freeport-McMoRan Inc. to Contact the Firm Today!**
- Source: CNYhomepage.com | 20251205T120758 | Neutral | Relevance: 99%
- Bronstein, Gewirtz & Grossman, LLC has filed a class action lawsuit against Freeport-McMoRan Inc. (NYSE: FCX) alleging violations of federal securities laws. The lawsuit claims the company made false statements and failed to disclose inadequate safety measures at its Grasberg Block Cave mine, leading to heightened risks for workers and investors. Investors who purchased Freeport securities between February 15, 2022, and September 24, 2025, are encouraged to contact the law firm to learn about their rights and the process to potentially become a lead plaintiff by January 12, 2026.

**5. Levi & Korsinsky Releases SueWallSt Podcast on Freeport-McMoRan Inc. (FCX) Lawsuit**
- Source: ABC4 Utah | 20251204T130838 | Neutral | Relevance: 99%
-  Levi & Korsinsky, LLP has released a new "SueWallSt" podcast detailing a class-action securities lawsuit filed against Freeport-McMoRan Inc. (FCX). The lawsuit alleges the company made false statements and concealed safety risks at its Grasberg Block Cave mine in Indonesia, which exposed workers to danger and led to undisclosed regulatory, litigation, and reputational risks. The firm encourages investors who lost money between February 15, 2022, and September 24, 2025, to contact them for more information.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 3)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-05 | JP Morgan | $58 | $50 | +16% |
| 2025-11-19 | Morgan Stanley | $44 | $46 | -4% |
| 2025-11-19 | BMO Capital | $47 | $48 | -2% |
| 2025-11-19 | Scotiabank | $47 | $51 | -8% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-05 | JP Morgan | main | Overweight |
| 2025-11-19 | Morgan Stanley | main | Overweight |
| 2025-11-19 | BMO Capital | main | Outperform |
| 2025-11-19 | Scotiabank | up | Sector Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 2 ($0.05M) |
| Sells | 1 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 39.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 9.0% (+1.4%)
- Blackrock Inc.: 7.4% (+0.6%)
- Fisher Asset Managem: 4.4% (+1.4%)
- State Street Corpora: 4.3% (+1.1%)
- Capital Research Glo: 2.9% (-31.2%)

### Key Risks

1. Valuation risk: PEG 3.0x with declining EPS estimates leaves no margin for error.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_10 improving +1.2% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 2.98 signals overvaluation risk, limited margin of safety. Forward P/E 21.3x attractive for 40% earnings growth. Balance sheet: strong liquidity (2.5x). Analyst sentiment negative (3 target cuts vs 1 raises). Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $64.3B |
| Beta | 1.48 |
| 52W Range | $27.66 - $49.12 |
| Short Interest | 1.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.98 |
| Forward P/E | 21.3 |
| Current P/E | 29.7 |
| YoY Growth | 39.9% |
| EPS Direction | FALLING |

### Technicals

MRS_10 strengthening from 2.9% to 4.1% (+1.2% in 5 days), confirming momentum buildup. Currently in lower STRENGTH zone (3.0-6.0%), cross-sectional ranking at 87th percentile. MRS_5 at 2.0% confirms short-term momentum alignment. Outperforming sector by 5.4pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (0.53), confirming momentum.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 4.12% (CS: 87) | Strong |
| RSI_14 | 66.8 | Neutral |
| MACD Histogram | 0.53 | Bullish |
| vs SMA20 | 1.087x | Above |
| vs SMA50 | 1.101x | Above |
| vs SMA200 | 1.115x | Above |

### Decision

- **Verdict:** BUY
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $45.20
- **Stop Loss:** $42.20 (6.6% risk)
- **Target:** $49.70 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 166
- **Position Value:** $7,503.20
- **Portfolio %:** 7.50%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite persisting. Mixed earnings signals with industrial weakness (John Deere) offset by consumer/tech strength, while institutional flows show selective positioning rather than broad risk-off. Fed meeting in 9 days provides near-term catalyst but current data suggests status quo maintenance.*

### Earnings

**Next:** 2026-01-22 (Est: $0.24)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.41 | $0.50 | +22.8% |
| 2025Q2 | $0.44 | $0.54 | +21.8% |
| 2025Q1 | $0.23 | $0.24 | +4.6% |
| 2024Q4 | $0.22 | $0.31 | +43.2% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*